Project Grant P20GM161969
- Federal Grant Award Summary The University of Oklahoma Health Sciences Center (OUHSC) received a $633,491 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2025, through June 30, 2030. The award supports the "Learning and Achievement in Biomedical Sciences" initiative, which aims to expand graduate education in biomedical sciences and address Oklahoma's significant...
- Federal Grant Award Summary The Oklahoma Medical Research Foundation (OMRF) received a $2.46 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded June 10, 2025, with a completion date of April 30, 2030. The award funds the establishment of the Center for Genomic Regulation (CGR), which serves as a collaborative research hub for the state of Oklahoma focused on advancing genomic...
- Federal Grant Award Summary The University of Oklahoma Health Sciences Center received a $393,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 8, 2025, with completion targeted for June 30, 2030. The grant funds fundamental research investigating the dynamics of fungal stress responses in host environments, utilizing Nakaseomyces glabratus as a model organism. Research...
- Federal Project Grant Award Summary The University of Oklahoma Health Sciences Center received a $700,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2027. This award funds a two-year investigator-initiated research project focused on elucidating the molecular, cellular, and organism-level mechanisms by which endothelial tetraspanins inhibit...
- The University of Oklahoma received a $2.55 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) beginning May 15, 2026, through January 31, 2031. This NIH Phase I COBRE (Centers of Biomedical Research Excellence) award establishes the Oklahoma Center of Immunoengineering (OCIE), which delivers integrated research infrastructure, training, and collaborative services to advance...
- Federal Project Grant Award Summary The University of Delaware received a $2.57 million Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2025, through February 28, 2030. This five-year Phase I Center of Biomedical Research Excellence (COBRE) grant funds the establishment of the Center for Biomedical Research Excellence in Multiscale Biomolecular Sensing (MBS), which...
- Federal Grant Award Summary The University of Oklahoma Health Sciences Center received a $700,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 4, 2025, with completion targeted for August 31, 2029. The award funds research investigating the role of ARID3A (A+T-Rich Interaction Domain Protein 3A) in autoimmune B cell dysfunction associated with systemic lupus erythematosus...
- Federal Grant Award Summary The University of Delaware received a $2.4 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 1, 2025, through May 31, 2030. This Phase III Center of Biomedical Research Excellence (COBRE) award supports the discovery of chemical probes and therapeutic lead molecules for biological research and therapeutic development. The center employs an...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Oklahoma Health Sciences Center a Project Grant of $116,574 on August 17, 2026, through the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The research project, titled "Determining the Role of Mitochondrial Hydrogen Peroxide in the Regulation of Neuronal Mitochondrial Networks," will be conducted at the...
- Federal Grant Award Summary The University of Mississippi Medical Center (UMMC) received a $2.6 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through July 31, 2030. This award establishes the Balance and Auditory Research Center (BARC) at UMMC to address significant gaps in vestibular and auditory neuroscience research. The center addresses critical...
The University of Oklahoma Health Sciences Center (OUHSC) received a $2.13 million Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), awarded May 1, 2026, with completion targeted for January 31, 2031. The award funds the Oklahoma Center for Biomedical Research Excellence in Sensory Biology (OCBRESB), a Center of Biomedical Research Excellence (COBRE) initiative designed to establish and advance the field of sensory biology at OUHSC. The center will investigate cellular mechanisms by which organisms sense their environment, utilizing diverse model organisms from C. elegans and algae to mice and human tissue. The OCBRESB will deliver research infrastructure and investigative services through an administrative core led by Dr. Leonidas Tsiokas and four integrated research projects focusing on sensory signaling mechanisms in vision, neurodevelopment, neuronal function, and neuropsychiatric disorders. The center will support two research cores providing state-of-the-art technical capabilities in super-resolution imaging and cell and genetic engineering. Research activities will encompass cell signaling studies across plasma membranes via sensory organelles including cilia and flagella, examination of specialized cell surface signaling domains such as dendrites and immunological synapses, and investigation of cell surface molecules including receptors and ion channels. The program will initially concentrate on cilia biology and associated disease mechanisms before expanding to encompass broader sensory modalities.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $2.1m | 5/5/26 |